Zhende Medical Co., Ltd. (SHA:603301)
82.00
-1.00 (-1.20%)
Nov 17, 2026, 3:00 PM CST
Zhende Medical Revenue
Zhende Medical had revenue of 1.29B CNY in the quarter ending September 30, 2026, with 18.58% growth. This brings the company's total for the last twelve months to 4.65B, up 7.68% year-over-year. In the year 2025, Zhende Medical had annual revenue of 4.33B with 1.54% growth. That makes Zhende Medical the 9,433rd largest company in the world by revenue and 1,507th in China.
Revenue (ttm)
4.65B
Revenue Growth
+7.68%
P/S Ratio
4.65
Revenue / Employee
588.56K
Employees
7,909
Market Cap
21.64B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Zhende Medical breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.33B | 65.71M | 1.54% |
| Dec 31, 2024 | 4.26B | 136.84M | 3.32% |
| Dec 31, 2023 | 4.13B | -2.01B | -32.76% |
| Dec 31, 2022 | 6.14B | 1.05B | 20.54% |
| Dec 31, 2021 | 5.09B | -5.31B | -51.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Intco Medical Technology | 13.12B |
| Winner Medical | 11.25B |
| Tofflon Science and Technology Group | 5.15B |
| Gan & Lee Pharmaceuticals. | 4.37B |
| Micro-Tech (Nanjing) Co.,Ltd | 3.32B |
| iRay Group | 3.20B |
| Imeik Technology Development | 2.33B |
| Autek China | 1.82B |